Trials / Unknown
UnknownNCT04260555
Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis
A Multicenter, Randomized, Double-Blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1601 Compared to DW16011 and DW16012 for Acute Bronchitis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 204 (estimated)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Randomized, Double-Blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1601 Compared to DW16011 and DW16012 for Acute Bronchitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW1601 | Total 7 days of treatment and The daily dose is tid. (DW1601 20ml + Placebo of DW16011 20ml + Placebo of DW16012 9ml) |
| DRUG | DW16011 | Total 7 days of treatment and The daily dose is tid. (Placebo of DW1601 20ml + DW16011 20ml + Placebo of DW16012 9ml) |
| DRUG | DW16012 | Total 7 days of treatment and The daily dose is tid. (Placebo of DW1601 20ml + Placebo of DW16011 20ml + DW16012 9ml) |
Timeline
- Start date
- 2018-12-20
- Primary completion
- 2019-12-09
- Completion
- 2021-02-28
- First posted
- 2020-02-07
- Last updated
- 2020-02-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04260555. Inclusion in this directory is not an endorsement.